<DOC>
	<DOCNO>NCT00194428</DOCNO>
	<brief_summary>The purpose trial study safety , tolerability efficacy almond enrich hypocaloric diet weight loss weight maintenance , well establish emerge cardiovascular risk factor approximately 112 overweight obese person .</brief_summary>
	<brief_title>Weight Metabolic Effects Almond Enriched Hypocaloric , Low Fat Diet Overweight Obese Persons</brief_title>
	<detailed_description>A randomized , non-blinded , control clinical trial use parallel design hypocaloric , low fat ( &lt; 30 % energy fat ) diet without 2 oz almond 18 month . Interim analyse conduct 3 , 6 , 9 12 month . The study divide 3 phase . Phase 1 ( month 0-6 ) active , intensive weight loss phase . During phase 1 , subject meet week even 1.5 hour . Phase 2 ( month 6-12 ) less intensive weight loss phase . During phase 2 group meet every week even 1.5 hour . The last phase weight maintenance phase phase 3 ( month 12-18 ) .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Body mass index ( BMI ) &gt; 27 &lt; 40 1875 year age Men nonpregnant lactate woman Subjects must willing comply studyrelated procedure Uncontrolled hypertension Diabetes use antihyperglycemic medication Dyslipidemia require prescription drug therapy define NCEP ATPIII guideline screen Known allergy sensitivity nut Known atherosclerotic cardiovascular disease History congestive heart failure History nonskin malignancy within previous 5 year Any major active rheumatologic , pulmonary , hepatic , renal , dermatologic disease inflammatory condition History HIV positive History alcohol drug abuse Weightloss inducing medication dietary supplement within 3 month prior enrollment . Weight loss &gt; 5 kg last 6 month Participation investigational drug study within 6 week prior screen Serious unstable medical psychological condition , opinion investigator , would compromise subject 's safety successful participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Obesity ,</keyword>
	<keyword>Metabolic Syndrome ,</keyword>
	<keyword>BMI</keyword>
</DOC>